Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): Pathophysiology, Molecular Mechanisms, and Therapeutic Advances
The Evolving Landscape of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: A Deep Dive into Pathophysiology and the Therapeutic Potential of GLP-1 Receptor Agonists and Poly-Agonist Peptides Many thanks to our sponsor Esdebe who helped […]
